• FDA Gives OTC Naloxone Pitch Another Go

    FDA Gives OTC Naloxone Pitch Another Go

    December 01, 2022 | 08:05am

    The FDA should reclassify the opioid overdose antidote naloxone, approved for use in 1971 to rescue overdose victims for the past few decades, as an over‐​the‐​counter drug.
See More Stories